![John Thompson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Thompson
Director/Board Member at NERVGEN PHARMA CORP.
Net worth: - $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bradley Margus | M | 63 |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 8 years |
Glenn Ives | M | 62 | 3 years | |
Harold Punnett | M | 67 | 7 years | |
Michael Kelly | M | 59 | 1 years | |
Krista McKerracher | F | - | 3 years | |
Adam Rogers | M | - | 2 years | |
Sally Susman | F | 62 | 17 years | |
Suzanne Johnson | F | 66 | 17 years | |
Brian Bayley | M | 71 | 6 years | |
Mark Carlton | M | - |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 8 years |
Aoife Brennan | M | 48 |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 4 years |
Mike McDermott | M | 58 | 21 years | |
Daniel Mikol | M | - | 3 years | |
Markus Green | M | - | 18 years | |
Matthias Kleinz | M | - |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
Annaliesa Anderson | M | - | 17 years | |
Laurence Barker | M | - |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
Stephen Hitchcock | M | - |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
Robert Poole | M | 67 |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 3 years |
John Ruffolo | M | - | 1 years | |
Randall Kaye | M | 61 | 4 years | |
Huitt Tracey | M | 64 | - | |
Mikael Dolsten | M | 65 | 15 years | |
Jason Lettmann | M | 46 |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | - |
David Lubner | M | 60 |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 4 years |
Bill Adams | M | 62 | 4 years | |
Barbara Dalton | M | 69 | 17 years | |
Sourav Kole | M | - |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | 2 years |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
United States | 86 | 86.00% |
Canada | 14 | 14.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Thompson
- Personal Network